scholarly journals Field Evaluation and Use of a Non Commercial Peptide Enzyme Immunoassay for Human Immunodeficiency Virus Serotyping in Abidjan (Ivory Coast)

Author(s):  
Inwoley A ◽  
Affi-Aboli R ◽  
Kabran M ◽  
Ouassa T ◽  
Koui S ◽  
...  
1999 ◽  
Vol 15 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Dennis L. Ellenberger ◽  
Danuta Pieniazek ◽  
John Nkengasong ◽  
Chi-Cheng Luo ◽  
Sushil Devare ◽  
...  

2002 ◽  
Vol 34 (5) ◽  
pp. 658-661 ◽  
Author(s):  
S. D. Shafran ◽  
B. Conway ◽  
E. Prasad ◽  
J. Greer ◽  
J. Vincelette ◽  
...  

2001 ◽  
Vol 8 (6) ◽  
pp. 1282-1285
Author(s):  
Debra Candal ◽  
Marc Bulterys ◽  
Elaine J. Abrams ◽  
Richard W. Steketee ◽  
Bharat S. Parekh

ABSTRACT We evaluated a less-sensitive enzyme immunoassay (3A11-LS) for its possible use for early diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants. The results were compared with those from the immunoglobulin G-capture enzyme immunoassay. A total of 239 sera from 77 infants were tested. All 25 sera from the 10 infants born to seronegative mothers were found to be negative by both assays. Forty-one seroreverting infants showed a complete decay of maternal antibodies by 4 months by the 3A11-LS assay. However, the assay detected HIV antibodies in only 9 (36%) of 25 sera collected from infected infants between 4 and 6 months and in 27 (63%) of 43 sera collected after 6 months of age. Further analysis with alternative cutoff values indicated that the 3A11-LS had a sensitivity of 12 to 44% and a specificity of 90 to 100% for infants between 4–6 months of age. This data suggest that a diagnosis of HIV infection in some of the infants could be made after 4 months of age by the 3A11-LS assay, although a negative 3A11-LS test result may not rule out infection and may require a further followup.


1995 ◽  
Vol 172 (5) ◽  
pp. 1371-1374 ◽  
Author(s):  
P. D. Ghys ◽  
M. O. Diallo ◽  
V. Ettiegne-Traore ◽  
K. M. Yeboue ◽  
E. Gnaore ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document